osteoporosis drugs and increased risk of oesophageal cancer...

A study recently published in the British Medical Journal suggests that long-term use of oral bisphosphonates for osteoporosis, such as Fosamax, Boniva and Actonel, may significantly increase a patient’s risk of developing oesophageal cancer.

The study found that patients who took the osteoporosis medications for five years or more had nearly double the risk of oesophageal cancer compared with those who had never taken the drugs. There was no increase in the risk of stomach or colorectal cancer.

The link between the use of bisphosphonate medications and oesophageal cancer first surfaced in 2009 when US Food and Drug Administration reports noted 23 cases of oesophageal cancer in patients who had taken Fosamax between 1995 and 2008.

» More Health Bites... click here